ARTICLE | Company News
ActoGeniX, Stallergenes deal
December 16, 2013 8:00 AM UTC
The companies partnered to develop allergy treatments using ActoGeniX's ActoBiotics mucosal delivery technology. ActoGeniX will develop clinical ActoBiotic candidates that express undisclosed predefin...